Pharma brands spent $3.9B on TV ads in 2021, led by Sanofi, Regeneron’s Dupixent and Novo Nordisk’s Rybelsus
Third-place is unfamiliar territory for AbbVie’s blockbuster drug Humira – even when it comes to TV ad spending. But that’s where the drug ended up in 2021 after AbbVie switched up Humira’s typically top-spend budget and reallocated some of its spending to newer sibling brands Rinvoq and Skyrizi.
The new No. 1 this year is Dupixent, Sanofi and Regeneron’s treatment approved in indications like asthma and eczema, according to data from realtime TV ad tracker iSpot.tv.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.